Skip Navigation


QJM Advance Access originally published online on September 19, 2007
QJM 2007 100(10):609-615; doi:10.1093/qjmed/hcm072
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/10/609    most recent
hcm072v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chan, A.
Right arrow Articles by Dufful, S.B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, A.
Right arrow Articles by Dufful, S.B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram

A. Chan1, G.K. Isbister1,2, C.M.J. Kirkpatrick1 and S.B. Dufful1,3

From the 1School of Pharmacy, University of Queensland, Brisbane, Australia, 2Menzies School of Health Research, Charles Darwin University, Darwin, Australia and 3School of Pharmacy, University of Otago, Dunedin, New Zealand

Address correspondence to Dr G.K. Isbister, Department of Clinical Toxicology, Newcastle Mater Hospital, Edith St, Waratah NSW 2298, Australia. email: geoffrey.isbister{at}menzies.edu.au

Received 10 April 2007 and in revised form 14 June 2007


   Abstract

Background: Although QT prolongation is associated with increased risk of torsade de pointes (TdP), the precise relationship is not well defined.

Aim: To evaluate the performance of a QT nomogram in assessing the risk of TdP from QT–RR combinations.

Design: Systematic review.

Methods: We systematically searched MEDLINE/EMBASE for cases of drug-induced TdP. Controls were patients taking non-cardiotoxic drugs in overdose. Inclusion criteria were definite TdP, normal ECG before or after the event, association with a drug/toxin and QT–RR measurements available. The upper bound of a QT–RR cloud diagram developed from human preclinical studies was converted into a QT nomogram [QT vs. heart rate (HR)]. QT–HR combinations for TdP cases and controls were plotted with the QT nomogram, and curves corresponding to a QTc = 440 ms and QTc = 500 ms for comparison (Bazett's correction).

Results: We identified 129 cases of TdP. TdP cases occurred at lower HR values with longer QT intervals, with most cases occurring at HR 30–90 bpm. Controls were more evenly distributed, with HR 40–160 bpm. The sensitivity and specificity of the QT nomogram were 96.9% (95%CI 93.9–99.9) and 98.7% (95%CI 96.8–100), respectively. For Bazett QTc = 440 ms, sensitivity and specificity were 98.5% (95%CI 96.3–100) and 66.7% (95%CI 58.6–74.7), respectively, whereas for Bazett QTc =500 ms they were 93.8% (95%CI 89.6–98.0) and 97.2% (95%CI 94.3–100), respectively.

Discussion: The QT nomogram is a clinically relevant risk assessment tool that accurately predicts arrhythmogenic risk for drug-induced QT prolongation. Further prospective evaluation of the nomogram is needed.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
Jeong Mi Moon and Byeong Jo Chun
Acute endosulfan poisoning: a retrospective study
Human and Experimental Toxicology, May 1, 2009; 28(5): 309 - 316.
[Abstract] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
M. Sala, M. Lazzaretti, G. De Vidovich, E. Caverzasi, F. Barale, G. d'Allio, and P. Brambilla
Electrophysiological changes of cardiac function during antidepressant treatment
Therapeutic Advances in Cardiovascular Disease, February 1, 2009; 3(1): 29 - 43.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.